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A retrospective case-control study was conducted to investigate the risk factors for pre-
eclampsia – including the protective effect of placenta previa – at Medani Maternity
Hospital, Sudan. Medical files of the patients during the period 2003–2010 were reviewed
for age, parity, education level, prenatal care, placenta previa, and hemoglobin level.Women
with pre-eclampsia were the cases, and women with normal pregnancy were the controls.
There were 54,339 singleton deliveries and 1765 women with pre-eclampsia in the hospi-
tal, giving the incidence of pre-eclampsia of 3.2%.The risk factors for pre-eclampsia were;
women with age >35 years (OR=1.4, 95% CI: 1.1–1.8), primiparity (OR=3.3, 95% CI:
2.7–4.0), para >5 (OR=3.1, 95% CI: 2.4–4.0), and anemia (OR=3.3, 95% CI: 2.8–3.9).
The risk of pre-eclampsia was inversely increased with education level and prenatal care
attendance. The prevalence of placenta previa was 0 (0%) and 55 (3.3%), P <0.001 in
pre-eclamptic and control women, respectively. Placenta previa was a significant protec-
tive factor of pre-eclampsia (OR=0.3, 95% CI: 0.1–0.7). Although, the socio-demographic
risk factors for pre-eclampsia observed among women at Medani hospital were similar to
those found in other settings; placenta previa was associated with decreased incidence of
pre-eclampsia.
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INTRODUCTION
Pre-eclampsia, is one of the most common complications of preg-
nancy, it affects approximately 10% of births (Robilland et al.,
2003). It is a leading cause of maternal and perinatal mortal-
ity worldwide (Duley, 2009). Although, the exact etiology of
pre-eclampsia is not yet known, many risk factors have been
demonstrated such as low education, primiparity, family history
of hypertension, obesity, younger and advanced maternal age,
and ethnicity (Conde-Agudelo and Belizán, 2000; Lee et al., 2000;
Roberts et al., 2003; Sibai et al., 2005; Adeyinka et al., 2010). There-
fore, if women at risk of pre-eclampsia are identified on the basis
of epidemiological and clinical risk factors, the awareness can be
raised, this will facilitate to make earlier diagnoses and predict
which patients are more likely to develop pre-eclampsia and can
help to monitor patients as well.
Most of the research on pre-eclampsia was conducted at set-
tings with good resources; few published data exist in low resources
settings (Conde-Agudelo and Belizán, 2000). Recently, it has been
shown that placenta previa is associated with low frequencies of
pre-eclampsia and low maternal blood pressure (Kiondo et al.,
2012). However, there are few published studies – with incon-
sistent findings – on the association between placenta previa
and pre-eclampsia. While some studies reported the protective
effects, other studies did show any associations, slightly increase in
the incidence and significantly elevated incidence pre-eclampsia
in placenta previa (Little and Friedman, 1964; Brenner et al.,
1978; Newton et al., 1984; Ananth et al., 1997; Hasegawa et al.,
2011).
There is an extremely high maternal mortality in Sudan with
pre-eclampsia/eclampsia accounting for 4.2% of the obstetric
complications and 18.1% of maternal deaths (Leiberman et al.,
1991; Ali and Adam, 2011; Ali et al., 2012). The current study
was conducted at Medani Maternity Hospital in Central Sudan to
investigate the potential risk factors for pre-eclampsia including
placenta previa. The data obtained is very useful for the health
planners, health providers, and augments the previous research
on pre-eclampsia in Sudan (Bakheit et al., 2009, 2010a,b; Elhassan
et al., 2009; Adam et al., 2011).
MATERIALS AND METHODS
A retrospective case – control study was conducted at labor ward
at Medani Maternity Hospital, Central Sudan. Medani Maternity
Hospital is a tertiary care hospital for women who receive prenatal
care at the hospital as well as for referrals from the other clinics and
hospitals. All women with risk factors or obstetric/medical com-
plications are referred to the hospital. However, the referral criteria
are not strictly adhered to and many women without any signifi-
cant complications are allowed to deliver at the hospital. Medical
files were reviewed for the patients during the period January 2003
through December 2010. A case was defined as a woman who had
given birth and who was diagnosed as being pre-eclamptic. Pre-
eclampsia is defined as pregnancy-induced hypertension associ-
ated with proteinuria. Pregnancy-induced hypertension is defined
as new hypertension with blood pressure of 140 mm Hg systolic or
diastolic blood pressure of 90 mm Hg diastolic or greater arising
after 20 weeks of gestation in a woman who is normotensive before
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20 weeks gestation. Proteinuria is defined as excretion of 300 mg
or more of protein in 24 h urine sample or ≥2+ on dipstick. A
consecutive control was taken for each case. Controls were par-
turient women admitted for delivery, without any blood pressure
values greater than 139/89 mm Hg or proteinuria recorded in the
pregnant health card during the antenatal visits and at the time of
delivery. Pregnant women with twins or diabetics were excluded,
because these were known predictors for pre-eclampsia (Adeyinka
et al., 2010). Placenta previa was diagnosed by ultrasound, con-
firmed during the cesarean delivery, and documented as such in
the medical file.
Data were entered in computer using SPSS for windows ver-
sion 16.0. Means and proportions were compared by Students’
t -test, X 2, and Fisher’s exact tests as appropriate. Univariate and
multivariate analyses were performed where pre-eclampsia was a
dependent variable and maternal characteristics, age (<20, 20–35,
and >35 years), parity (primiparae, 2–5 and para >5), educa-
tional levels (illiterate, secondary level≥ university), and prenatal
care (none, once and twice, and >twice), anemia (Hemoglobin
<11 gm/dl), and placenta previa as possible influencing factors.
Odds ratio and 95% confidence interval were calculated. P < 0.05
was regarded as significant.
ETHICS
This was a retrospective study in which the data in the files of the
patients were analyzed anonymously and no fresh personal data
were required. The study was approved by the local ethical board
of the institution.
RESULTS
During the study period there were 54,339 singleton deliveries
among which 1765 women were diagnosed as pre-eclampsia, with
the incidence of 3.2%. Out of these women, 1645 had com-
plete data concerning age, parity, education level, prenatal care,
placenta previa, and hemoglobin levels and they were included
in the final analyses. The excluded 120 women had no placenta
previa (excluded by ultrasound) but were not included in the
final analyses because of other missing data sets (educational level
etc.).
Compared with the controls, significantly higher numbers of
pre-eclamptic women had less level of education, prenatal care
attendance, and had anemia, Table 1. The mean (SD) age of the
pre-eclamptic women was significantly higher than in the con-
trols, 29.0 (6.3) vs. 28.4(6.0) years, P = 0.003. There was no case
of severe anemia (hemoglobin <7 g/dl).
The prevalence of placenta previa was 0 (0%) and 55 (3.3%),
P < 0.001 in pre-eclamptic and control women, respectively
(Table 1).
In logistic regression, the risk factor for pre-eclampsia
increased with age, i.e., in comparison to the women with
age ranged 20–34 years, younger women (<20 years) were
less likely to have pre-eclampsia (OR= 0.2, 95% CI: 0.1–
0.3; P < 0.001), women with age >35 years were at higher
risk for pre-eclampsia (OR= 1.4, 95% CI: 1.1–1.8; P = 0.004;
Table 2).
The other risk factors for pre-eclampsia were primipar-
ity (OR= 3.3, 95% CI: 2.7–4.0; P < 0.001) and para >5
Table 1 | Comparing age, parity, educational levels, prenatal care,
anemia, and placenta previa between the cases and controls.
The variable Pre-eclamptic
women (n=1645)
Controls
(n=1645)
P
Age groups in years
<20 65 (4) 121 (7.4) <0.001
20–35 1294 (78.7) 1304 (79.3) 0.7
>35 286 (17.4) 220 (13.4) 0.001
Parity groups
Primiparae 585 (35.6) 294 (18.0) <0.001
2–5 724 (44.0) 1217 (74) <0.001
>5 336 (20.4) 134 (8.0) <0.001
Educational level
Illiterate 451 (27.4) 423 (25.7) 0.2
Secondary 1116 (67.8) 1087 (66.1) 0.2
>Secondary 78 (4.7) 135 (8.2) <0.001
Prenatal care visit
None 409 (24.9) 235 (14.3) <0.001
One and two 967 (58.8) 835 (50.8) <0.001
>Two 269 (16.3) 575 (35.0) <0.001
Anemia 1287 (78.2) 738 (44.9) <0.001
Placenta previa 0 (0.0) 55 (3.3) <0.001
Table 2 | Risk factors for pre-eclampsia in Medani Hospital using
univariate and multivariate analyses.
The variable Univariate analysis Multivariate analysis
OR 95% CI P OR 95% CI P
Age groups in years
<20 0.4 0.3–0.7 <0.001 0.2 0.1–0.3 <0.001
20–35 Adam et al. (2011)
>35 1.3 1.0–1.5 0.006 1.4 1.1–1.8 0.004
Parity groups
Primiparae 3.3 2.8–3.9 <0.001 3.3 2.7–4.0 <0.001
2–5 Adam et al. (2011)
>5 4.2 3.3–5.2 <0.001 3.1 2.4–4.0 <0.001
Educational level
Illiterate 1.8 1.3–2.5 <0.001 2.6 2.0–3.5 <0.001
Secondary 1.7 1.3–2.3 <0.001 1.4 1.1–1.8 0.004
>Secondary Adam et al. (2011)
Prenatal care
None 3.7 3.0–4.6 <0.001 4.2 2.9–6.0 <0.001
Once and twice 2.4 2.0–2.9 <0.001 1.7 1.3–2.1 <0.001
>Twice Adam et al. (2011)
Anemia 4.4 3.8–5.1 <0.001 3.3 2.8–3.9 <0.001
Placenta previa 0.1 0.07–0.3 <0.001 0.3 0.1–0.7 0.006
(OR= 3.1, 95% CI: 2.4–4.0; P < 0.001) and anemia (OR= 3.3,
95% CI: 2.8–3.9 P < 0.001). The risk of pre-eclampsia was
inversely increased with education level and prenatal care atten-
dance.
Placenta previa was a significant protective factor of pre-
eclampsia (OR= 0.3, 95% CI: 0.1–0.7; P = 0.006; Table 2).
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DISCUSSION
Perhaps this is the largest data on pre-eclampsia in Africa. In the
current study, age (elder age) and parity (primiparae and para
>5), low levels of education and low prenatal care attendance
were the risk factors for pre-eclampsia. Recently, low education
level, primiparity and para ≥5 were shown to be the risk factors
for pre-eclampsia in neighboring Uganda (Conde-Agudelo and
Belizán, 2000) whereas age and parity were observed to be the risk
factors for pre-eclampsia among Latin American and Caribbean
women (Adeyinka et al., 2010).
The current study showed that anemic women were three times
at higher risk for pre-eclampsia. In eastern Sudan, it has been
shown that risk of pre-eclampsia increased only in severe ane-
mia (Hemoglobin <7 gm/dl) and pregnant women with severe
anemia were 3.6 times (OR= 3.6, 95% CI: 1.4–9.1) at risk of pre-
eclampsia (Ali et al., 2011). The association between pre-eclampsia
and anemia might be explained by micronutrient deficiency. Inter-
estingly, it has recently been shown that pregnant women with
low levels of vitamin C were at higher risk for pre-eclampsia
(Conde-Agudelo and Belizán, 2000). However, it might be dif-
ficult to explore if anemia was the cause or effect of pre-eclampsia
in the current study and anemia might have been a consequence
of the disease process. On the contrary, anemia was reported
recently as protective for pre-eclampsia (OR= 0.5, 95%= 0.3–
0.9; Kashanian et al., 2011). Yet, in the later study the cut-off was
not defined for hemoglobin levels and prevalence of anemia was
not significantly different between the cases of pre-eclampsia and
controls.
In the present study the incidence of placenta previa was 0
and 3.3% among women with pre-eclampsia and controls, respec-
tively and the risk of pre-eclampsia was reduced by one third
among women with placenta previa (OR= 0.3, 95% CI: 0.1–0.7).
This goes with the previous studies where it has been shown that
the risk of pregnancy-induced hypertension was reduced by half
among those with placenta previa (OR= 0.5, 95% CI: 0.3–0.7; Lit-
tle and Friedman, 1964). Moreover, patients with placenta previa
had a third of the risk for hypertensive disorders compared with
pregnant women with normally implanted placentae (OR= 0.36,
95% CI: 0.20–0.64; Ananth et al., 1997). Interestingly, recently
Hasegawa et al. (2011) have found that not only placenta previa
but also low cord insertion were associated with low frequencies
of pre-eclampsia and low maternal blood pressure.
It has been suggested that pre-eclampsia originates in the
placenta, with inadequate cytotrophoblast invasion, widespread
maternal endothelial dysfunction (Brosens, 1977; Wang et al.,
2009). During normal early placental development extravillous
fetal cytotrophoblasts invade the uterine spiral arteries of the
decidua and myometrium and replace the endothelial layer of the
maternal spiral arteries, transforming them into large capacitance
vessels to provide adequate placental perfusion for the growing
fetus. It has been speculated that the blood supply and oxygena-
tion of a placenta implanted in the lower uterine segment are
increased compared with those in a placenta implanted in the
upper uterine segment because the blood flow to the lower uter-
ine segment is less affected by the pressure of the myometrium
(Ananth et al., 1997). The improved blood supply and oxygena-
tion of the placenta previa might explain the decreased incidence
of pre-eclampsia.
In summary, the socio-demographic risk factors for pre-
eclampsia observed among women at Medani hospital were similar
to those found in other settings; placenta previa was associated
with decreased incidence of pre-eclampsia.
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